Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP: Adjuvant Therapy in Prostate Carcinoma Treatment
NCT00132301Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2006
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by VA Office of Research & Development. Started Jun 2006; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00132301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132301.